At 30/1 the pps only has to be $0.15 to reach $4.50. That is very doable with the ITLD and JV. So this leads me into another thought. I can see $0.25 - $0.50 pps with a ITLD and JV, maybe even a little more.
$0.25 * 30/1 = $7.50
$0.50 * 30/1 = $15.00
The $0.25 * 30/1 = $7.50 is well over the amount required to uplist. Any thoughts if we will go back to the BOD for a revote for a low RS?
Sky, I don't think they need to think about a RS at all. The truth is if they did it now ,or earlier when Rabin was pushing for it, it would've been an unmitigated disaster, because w/o profits the people who short stocks would've of swooped in and destroyed it.
What they should do after they go to market with the macular degeneration cures, would be to start buying back shares, because this would increase shareholder value, something that ACT has been adverse at doing for almost 10 years now.
Just dreaming a bit here, but when their profits become huge, thats when they should start paying out a dividend.